• Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business En-CPhI.CN
    October 15, 2019
    Admedus Limited announces the sale of its CardioCel® and VascuCel® patch business to U.S based LeMaitre Vascular Inc., for up to $A36.2M ($A22.8M upfront) in cash payments to Admedus.
  • Admedus launches ADAPT technology in India October 11, 2018
    Physicians in India can now access the transformative power and significant patient benefits of ADAPT® engineered tissue and Admedus’ flagship product CardioCel® which is a bio-scaffold for the management of congenital and adult structural heart abnormali
PharmaSources Customer Service